UniProt ID | PLTP_HUMAN | |
---|---|---|
UniProt AC | P55058 | |
Protein Name | Phospholipid transfer protein | |
Gene Name | PLTP | |
Organism | Homo sapiens (Human). | |
Sequence Length | 493 | |
Subcellular Localization | Secreted. | |
Protein Description | Facilitates the transfer of a spectrum of different lipid molecules, including diacylglycerol, phosphatidic acid, sphingomyelin, phosphatidylcholine, phosphatidylglycerol, cerebroside and phosphatidyl ethanolamine. Essential for the transfer of excess surface lipids from triglyceride-rich lipoproteins to HDL, thereby facilitating the formation of smaller lipoprotein remnants, contributing to the formation of LDL, and assisting in the maturation of HDL particles. PLTP also plays a key role in the uptake of cholesterol from peripheral cells and tissues that is subsequently transported to the liver for degradation and excretion. Two distinct forms of PLTP exist in plasma: an active form that can transfer PC from phospholipid vesicles to high-density lipoproteins (HDL), and an inactive form that lacks this capability.. | |
Protein Sequence | MALFGALFLALLAGAHAEFPGCKIRVTSKALELVKQEGLRFLEQELETITIPDLRGKEGHFYYNISEVKVTELQLTSSELDFQPQQELMLQITNASLGLRFRRQLLYWFFYDGGYINASAEGVSIRTGLELSRDPAGRMKVSNVSCQASVSRMHAAFGGTFKKVYDFLSTFITSGMRFLLNQQICPVLYHAGTVLLNSLLDTVPVRSSVDELVGIDYSLMKDPVASTSNLDMDFRGAFFPLTERNWSLPNRAVEPQLQEEERMVYVAFSEFFFDSAMESYFRAGALQLLLVGDKVPHDLDMLLRATYFGSIVLLSPAVIDSPLKLELRVLAPPRCTIKPSGTTISVTASVTIALVPPDQPEVQLSSMTMDARLSAKMALRGKALRTQLDLRRFRIYSNHSALESLALIPLQAPLKTMLQIGVMPMLNERTWRGVQIPLPEGINFVHEVVTNHAGFLTIGADLHFAKGLREVIEKNRPADVRASTAPTPSTAAV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
28 | O-linked_Glycosylation | GCKIRVTSKALELVK CCEEEEEHHHHHHHH | 17.05 | 31637018 | |
64 | N-linked_Glycosylation | KEGHFYYNISEVKVT CCCEEEEEECEEEEE | 21.67 | 17623646 | |
64 | N-linked_Glycosylation | KEGHFYYNISEVKVT CCCEEEEEECEEEEE | 21.67 | 17623646 | |
93 | Phosphorylation | QELMLQITNASLGLR HHHHHHHHHHHHHHH | 16.27 | 18669648 | |
94 | N-linked_Glycosylation | ELMLQITNASLGLRF HHHHHHHHHHHHHHH | 29.21 | 16335952 | |
96 | Phosphorylation | MLQITNASLGLRFRR HHHHHHHHHHHHHHH | 25.66 | 18669648 | |
117 | N-linked_Glycosylation | FYDGGYINASAEGVS ECCCCEEEEECCCEE | 21.25 | 21515415 | |
143 | N-linked_Glycosylation | AGRMKVSNVSCQASV CCCCEECCCEECCCH | 32.48 | 18638581 | |
165 | Phosphorylation | GGTFKKVYDFLSTFI CCHHHHHHHHHHHHH | 15.17 | 25072903 | |
169 | Phosphorylation | KKVYDFLSTFITSGM HHHHHHHHHHHHHHH | 22.67 | 25072903 | |
170 | Phosphorylation | KVYDFLSTFITSGMR HHHHHHHHHHHHHHH | 22.62 | 25072903 | |
173 | Phosphorylation | DFLSTFITSGMRFLL HHHHHHHHHHHHHHH | 18.29 | 25072903 | |
174 | Phosphorylation | FLSTFITSGMRFLLN HHHHHHHHHHHHHHH | 26.27 | 25072903 | |
245 | N-linked_Glycosylation | FFPLTERNWSLPNRA CCCCCCCCCCCCCCC | 26.84 | 19139490 | |
376 | Ubiquitination | MDARLSAKMALRGKA HHHHHHHHHHHCCHH | 22.72 | - | |
398 | N-linked_Glycosylation | RRFRIYSNHSALESL HHHCCCCCCCHHHHH | 19.03 | 16335952 | |
398 | N-linked_Glycosylation | RRFRIYSNHSALESL HHHCCCCCCCHHHHH | 19.03 | 17623646 | |
483 | O-linked_Glycosylation | RPADVRASTAPTPST CCCCCCCCCCCCCCC | 17.97 | 55833439 | |
484 | O-linked_Glycosylation | PADVRASTAPTPSTA CCCCCCCCCCCCCCC | 35.35 | 55833445 | |
487 | O-linked_Glycosylation | VRASTAPTPSTAAV- CCCCCCCCCCCCCC- | 27.66 | 55833449 | |
489 | O-linked_Glycosylation | ASTAPTPSTAAV--- CCCCCCCCCCCC--- | 32.91 | 55833453 | |
490 | O-linked_Glycosylation | STAPTPSTAAV---- CCCCCCCCCCC---- | 21.60 | 55833459 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PLTP_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PLTP_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PLTP_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-64, AND MASS SPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-64; ASN-94; ASN-143;ASN-245 AND ASN-398, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-93 AND SER-96, AND MASSSPECTROMETRY. |